TY - JOUR
T1 - ND3, ND1 and 39 kDa subunits are more exposed in the de-active form of bovine mitochondrial complex i
AU - Babot, M.
AU - Labarbuta, P.
AU - Birch, Amanda
AU - Kee, S.
AU - Fuszard, M.
AU - Botting, C.H.
AU - Wittig, I.
AU - Heide, H.
AU - Galkin, A.
N1 - This study was supported by MRC grants G1100051 (to A.G.) and by the Cluster of Excellence “Macromolecular Complexes” at the Goethe University Frankfurt [EXC 115], the Deutsche Forschungsgemeinschaft Sonderforschungsbereich 815
project Z1-Redox-Proteomics and by the Bundesministerium für Bildung und Forschung Grant BMBF [01GM1113B] mitoNET-Deutsches Netzwerk für mitochondriale Erkrankungen (to I.W.).
PY - 2014/6/1
Y1 - 2014/6/1
N2 - An intriguing feature of mitochondrial complex I from several species is the so-called A/D transition, whereby the idle enzyme spontaneously converts from the active (A) form to the de-active (D) form. The A/D transition plays an important role in tissue response to the lack of oxygen and hypoxic deactivation of the enzyme is one of the key regulatory events that occur in mitochondria during ischaemia. We demonstrate for the first time that the A/D conformational change of complex I does not affect the macromolecular organisation of supercomplexes in vitro as revealed by two types of native electrophoresis. Cysteine 39 of the mitochondrially-encoded ND3 subunit is known to become exposed upon de-activation. Here we show that even if complex I is a constituent of the I + III + IV (S) supercomplex, cysteine 39 is accessible for chemical modification in only the D-form. Using lysine-specific fluorescent labelling and a DIGE-like approach we further identified two new subunits involved in structural rearrangements during the A/D transition: ND1 (MT-ND1) and 39 kDa (NDUFA9). These results clearly show that structural rearrangements during de-activation of complex I include several subunits located at the junction between hydrophilic and hydrophobic domains, in the region of the quinone binding site. De-activation of mitochondrial complex I results in concerted structural rearrangement of membrane subunits which leads to the disruption of the sealed quinone chamber required for catalytic turnover. Crown
AB - An intriguing feature of mitochondrial complex I from several species is the so-called A/D transition, whereby the idle enzyme spontaneously converts from the active (A) form to the de-active (D) form. The A/D transition plays an important role in tissue response to the lack of oxygen and hypoxic deactivation of the enzyme is one of the key regulatory events that occur in mitochondria during ischaemia. We demonstrate for the first time that the A/D conformational change of complex I does not affect the macromolecular organisation of supercomplexes in vitro as revealed by two types of native electrophoresis. Cysteine 39 of the mitochondrially-encoded ND3 subunit is known to become exposed upon de-activation. Here we show that even if complex I is a constituent of the I + III + IV (S) supercomplex, cysteine 39 is accessible for chemical modification in only the D-form. Using lysine-specific fluorescent labelling and a DIGE-like approach we further identified two new subunits involved in structural rearrangements during the A/D transition: ND1 (MT-ND1) and 39 kDa (NDUFA9). These results clearly show that structural rearrangements during de-activation of complex I include several subunits located at the junction between hydrophilic and hydrophobic domains, in the region of the quinone binding site. De-activation of mitochondrial complex I results in concerted structural rearrangement of membrane subunits which leads to the disruption of the sealed quinone chamber required for catalytic turnover. Crown
KW - Complex I
KW - NADH:ubiquinone oxidoreductase
KW - A/D transition
KW - Conformational change
KW - Protein tyrosine modification
KW - N -hydroxysuccinimide
UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-84897352802&partnerID=8YFLogxK
U2 - 10.1016/j.bbabio.2014.02.013
DO - 10.1016/j.bbabio.2014.02.013
M3 - Article
AN - SCOPUS:84897352802
SN - 0005-2728
VL - 1837
SP - 929
EP - 939
JO - Biochimica et Biophysica Acta - Bioenergetics
JF - Biochimica et Biophysica Acta - Bioenergetics
IS - 6
ER -